CareerPlan

Senior Director, Head of Payer Strategy & Engagement

Full-time2026-11-06 → 2026-11-19
Hybrid

Core

Lead U.S. payer strategy and account engagement for the launch of Deramiocel, a cell therapy for Duchenne muscular dystrophy, constructing the payer value platform and driving coverage and contracting decisions.

Role type

Senior Director, Head of Payer Strategy & Engagement

Builds

U.S. payer access and reimbursement pathways for a rare-disease cell therapy

Domain

Biotechnology / Cell and Gene Therapy / Market Access

Deliverable

client delivery

Required skills

U.S. payer strategy, HTA, market access leadership, rare-disease launch experience, HEOR, medical-benefit reimbursement, coding (HCPCS/ICD-10), account management, contracting strategy, team leadership

Preferred skills

Cell or gene therapy payer engagement, global market access, outcomes-based contracting, established relationships with national/regional payers and PBMs

Technologies

AMCP dossiers, budget-impact models, policy response tools

Responsibilities

Develop U.S. payer strategy across commercial, Medicare, and Medicaid segments; Construct the deramiocel payer value platform including value decks and budget-impact models; Drive HCPCS code application and ICD-10 coding initiatives; Lead the National Account Director team in engagement with national and regional payers, PBMs, and IDNs; Develop and oversee execution of commercial, Medicaid, and outcomes-based contracting arrangements; Align HEOR and clinical evidence-generation efforts with payer and HTA expectations.

Seniority

Senior Director, hands-on IC with team management